Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Altafaj

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Frontiers in Pharmacology|December 8, 2025
EAR-20 peptide, a novel NMDA receptor positive allosteric modulatorRoberto García-Díaz, Aida Castellanos, Federico Miguez-Cabello, et al.
Journal of Inherited Metabolic Disease|November 7, 2023
Metabolic characterization of neurogenetic disorders involving glutamatergic neurotransmissionSofía Illescas, Yaiza Diaz-Osorio, Anna Serradell, et al.
Human Molecular Genetics|October 12, 2020
Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-functionAna Santos-Gómez, Federico Miguez-Cabello, Adrián García-Recio, et al.
Biological Psychiatry|July 24, 2017
Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary SupplementDavid Soto, Mireia Olivella, Cristina Grau, et al.
Oncotarget|August 25, 2016
Glutamatergic stimulation induces GluN2B translation by the nitric oxide-Heme-Regulated eIF2α kinase in cortical neuronsEva Ramos-Fernández, Marta Tajes, Gerard Ill-Raga, et al.
International Journal of Molecular Sciences|December 10, 2021
Paradigmatic De Novo <i>GRIN1</i> Variants Recapitulate Pathophysiological Mechanisms Underlying GRIN1-Related Disorder Clinical SpectrumAna Santos-Gómez, Federico Miguez-Cabello, Natalia Juliá-Palacios, et al.
Science Signaling|June 20, 2019
L-Serine dietary supplementation is associated with clinical improvement of loss-of-function <i>GRIN2B</i>-related pediatric encephalopathyDavid Soto, Mireia Olivella, Cristina Grau, et al.
Brain : a Journal of Neurology|February 21, 2024
L-serine treatment in patients with GRIN-related encephalopathy: a phase 2A, non-randomized studyNatalia Juliá-Palacios, Mireia Olivella, Mariya Sigatullina Bondarenko, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Frontiers in Pharmacology|December 8, 2025
EAR-20 peptide, a novel NMDA receptor positive allosteric modulatorRoberto García-Díaz, Aida Castellanos, Federico Miguez-Cabello, et al.
Journal of Inherited Metabolic Disease|November 7, 2023
Metabolic characterization of neurogenetic disorders involving glutamatergic neurotransmissionSofía Illescas, Yaiza Diaz-Osorio, Anna Serradell, et al.
Human Molecular Genetics|October 12, 2020
Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-functionAna Santos-Gómez, Federico Miguez-Cabello, Adrián García-Recio, et al.
Biological Psychiatry|July 24, 2017
Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary SupplementDavid Soto, Mireia Olivella, Cristina Grau, et al.
Oncotarget|August 25, 2016
Glutamatergic stimulation induces GluN2B translation by the nitric oxide-Heme-Regulated eIF2α kinase in cortical neuronsEva Ramos-Fernández, Marta Tajes, Gerard Ill-Raga, et al.
International Journal of Molecular Sciences|December 10, 2021
Paradigmatic De Novo <i>GRIN1</i> Variants Recapitulate Pathophysiological Mechanisms Underlying GRIN1-Related Disorder Clinical SpectrumAna Santos-Gómez, Federico Miguez-Cabello, Natalia Juliá-Palacios, et al.
Science Signaling|June 20, 2019
L-Serine dietary supplementation is associated with clinical improvement of loss-of-function <i>GRIN2B</i>-related pediatric encephalopathyDavid Soto, Mireia Olivella, Cristina Grau, et al.
Brain : a Journal of Neurology|February 21, 2024
L-serine treatment in patients with GRIN-related encephalopathy: a phase 2A, non-randomized studyNatalia Juliá-Palacios, Mireia Olivella, Mariya Sigatullina Bondarenko, et al.
Pageof 4